Daniel J. Curran - Oct 21, 2021 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Oct 21, 2021
Transactions value $
$0
Form type
3
Date filed
10/21/2021, 08:46 PM
Next filing
Jun 17, 2024

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney